The chief technology and chief executive officer of Mustang Bio discussed the company’s integrated approach to drug development.
Knut Niss, PhD
Advertisement
Chief technology officer, Mustang Bio
Articles by Knut Niss, PhD
The chief technology officer of Mustang Bio discussed the company’s approach and future plans in CAR T production.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Naji Gehchan, MD, MBA, on Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis
2
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
3
Quarter Century Update: Future Predictions for the Field
4
Quarter Century Update: What Does the Field Need Most Right Now?
5
